Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00483834
What this trial is testing

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University Health Network, Toronto 50
Testing effectiveness (Phase 2)Study completedNCT00817284
What this trial is testing

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Ulrik Lassen 60
Early research (Phase 1)Study completedNCT03295084
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors

Who this might be right for
Metastatic Colorectal Cancer
Dorte Nielsen 39
Not applicableWithdrawnNCT01939483
What this trial is testing

A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS Metastases

Who this might be right for
Central Nervous System MetastasesMale Breast CancerRecurrent Breast Cancer+1 more
University of California, Irvine
Early research (Phase 1)Study completedNCT01009073
What this trial is testing

A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer Subjects

Who this might be right for
Solid Tumors
AbbVie (prior sponsor, Abbott) 51
Testing effectiveness (Phase 2)Looking for participantsNCT05319639
What this trial is testing

Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

Who this might be right for
Gastric Cancer Stage IV
Fujian Cancer Hospital 51
Testing effectiveness (Phase 2)Ended earlyNCT03168594
What this trial is testing

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Peking University 66
Large-scale testing (Phase 3)Study completedNCT00063141
What this trial is testing

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,302
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134205
What this trial is testing

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai JMT-Bio Inc. 252
Large-scale testing (Phase 3)Not Yet RecruitingNCT07074353
What this trial is testing

Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT06766019
What this trial is testing

Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 47
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Testing effectiveness (Phase 2)UnknownNCT03400592
What this trial is testing

Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric Adenocarcinoma

Who this might be right for
Stomach Neoplasms
Peking University 55
Not applicableUnknownNCT06155136
What this trial is testing

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Who this might be right for
Pancreatic Cancer Metastatic
Servier Affaires Médicales 163
Testing effectiveness (Phase 2)UnknownNCT05143099
What this trial is testing

Phase II Study of Tislelizumab Combined With Cetuximab and Irinotecan in the Treatment of Recurrent, Refractory mCRC

Who this might be right for
Colorectal Neoplasms
Shanghai Zhongshan Hospital 35
Testing effectiveness (Phase 2)Study completedNCT02244632
What this trial is testing

Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
Isofol Medical AB 105
Testing effectiveness (Phase 2)WithdrawnNCT04543916
What this trial is testing

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

Who this might be right for
Relapsed Small Cell Lung CancerRefractory Small Cell Lung Carcinoma
Virginia Commonwealth University
Not applicableStudy completedNCT00369109
What this trial is testing

Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer
Barbara Ann Karmanos Cancer Institute 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06199973
What this trial is testing

Injection of SHR-A1811 Versus Physician Choiced Treatment in Patients With Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-fu, and Irinotecan

Who this might be right for
Advanced Colorectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 130
Early research (Phase 1)Active Not RecruitingNCT05277766
What this trial is testing

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesColorectal Cancer+5 more
University Hospital, Ghent 45
Next Page